Cancer cells, myeloid-derived suppressor cells (MDSCs), and tumor-associated fibroblasts can reduce tryptophan levels through the enzymatic activity of indoleamine 2,3-dioxygenase (IDO) (21). Here, IDO1 is linked to neoplasm.